| Description | Levosalbutamol Hydrochloride is a β2-adrenergic receptor agonist. It is used to treat asthma and chronic obstructive pulmonary disease. |
| Synonyms | R-albuterol, R albuterol, Xopenex, (R)-albuterol |
| molecular weight | 275.77 |
| Molecular formula | C13H22ClNO3 |
| CAS | 50293-90-8 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Solubility | DMSO: Soluble |
| References | 1. Brunetti L, Poiani G, Dhanaliwala F, Poppiti K, Kang H, Suh DC. Clinical outcomes and treatment cost comparison of levalbuterol versus albuterol in hospitalized adults with chronic obstructive pulmonary disease or asthma. Am J Health Syst Pharm. 2015 Jun 15;72(12):1026-35. doi: 10.2146/ajhp140551. PubMed PMID: 26025994. 2. Yuan J, Lu ZK, Zhang Y, Wu J, Love BL, Schulz RM. Clinical outcomes of levalbuterol versus racemic albuterol in pediatric patients with asthma: Propensity score matching approach in a medicaid population. Pediatr Pulmonol. 2016 Oct 4. doi: 10.1002/ppul.23565. PubMed PMID: 27701831. 3. Arroyo MG, Couëtil LL, Nogradi N, Kamarudin MM, Ivester KM. Efficacy of Inhaled Levalbuterol Compared to Albuterol in Horses with Recurrent Airway Obstruction. J Vet Intern Med. 2016 Jul;30(4):1333-7. doi: 10.1111/jvim.14320. Epub 2016 Jun 9. PubMed PMID: 27282625. 4. New drug overview. Levalbuterol hydrochloride. Am J Health Syst Pharm. 1999 Jun 15;56(12):1191. PubMed PMID: 10484651. |